TJ
Thompson Jaye Other
US US · SEC (Form 4)
€73,692
▲ Purchases (7 ops.)
Browse the detailed record of transactions filed by Thompson Jaye. Insider active across 1 companies, notably Greenwich LifeSciences, Inc.. In total, 7 reports have been published. Total volume traded: €74k. The latest transaction was filed on 19 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 7 total
€7,754 500 shares @ €15.5079 0.0021% mcap 10.5% of flow
Common Stock
SEC:0001493152-22-010484:0 · 19 Apr 2022
Ideal exit: 14 Jan 2023 (T+270) €8,281 500 shares @ €16.5615 0.0022% mcap 25.1% of flow
Common Stock
SEC:0001493152-22-002817 · 31 Jan 2022
Ideal exit: 28 Oct 2022 (T+270) €8,281 500 shares @ €16.5615 0.0022% mcap 11.2% of flow
Common Stock
SEC:0001493152-22-002817:0 · 31 Jan 2022
Ideal exit: 28 Oct 2022 (T+270) €7,217 500 shares @ €14.4338 0.0019% mcap 21.9% of flow
Common Stock
SEC:0001493152-22-002021 · 21 Jan 2022
Ideal exit: 18 Oct 2022 (T+270) €7,217 500 shares @ €14.4338 0.0019% mcap 9.8% of flow
Common Stock
SEC:0001493152-22-002021:0 · 21 Jan 2022
Ideal exit: 18 Oct 2022 (T+270) €17,471 1,000 shares @ €17.4713 0.0046% mcap 53.0% of flow
Common Stock
SEC:0001493152-22-001189 · 13 Jan 2022
Ideal exit: 10 Oct 2022 (T+270) €17,471 1,000 shares @ €17.4713 0.0046% mcap 23.7% of flow
Common Stock
SEC:0001493152-22-001189:0 · 13 Jan 2022
Ideal exit: 10 Oct 2022 (T+270) About Thompson Jaye Jaye Thompson is a director at Greenwich LifeSciences, Inc.